Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 17Uterine Cervical Neoplasms 11Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Ovarian Neoplasms 8Neoplasms 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 7Fallopian Tube Neoplasms 6Colorectal Neoplasms 5Recurrence 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Head and Neck Neoplasms 4Colonic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Nasopharyngeal Carcinoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Esophageal Squamous Cell Carcinoma 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Hereditary Breast and Ovarian Cancer Syndrome × Clear all
NCT03162276 2018-09-07

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Sheba Medical Center

Phase 3 Unknown
118 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡